Drugs / DPCP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05438290 | Sep 2022 → May 2023 | neurofibroma | Nicholas Gulati | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DPCP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05438290 ↗ |
| Route | Topical | “DPCP applied topically to their neurofibromas once weekly for 10 weeks” NCT05438290 ↗ |